For AbbVie’s blockbuster Humira, cheaper competitors pose surprisingly little threat, analysts say
June 30, 2023 at 13:28 PM EDT
Lower-price biosimilar competition for top-selling drug launching this weekend.
 |
||||||||||||
|
||||||||||||
| About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map | ||||||||||||
Photos copyright by Jay Graham Photographer
